ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,720 | +153.1% | 23,993 | +127.2% | 0.00% | – |
| Q2 2023 | $108,547 | +59.9% | 10,559 | +20.0% | 0.00% | – |
| Q1 2023 | $67,905 | +2.2% | 8,796 | -2.7% | 0.00% | – |
| Q4 2022 | $66,429 | +51.0% | 9,038 | +46.6% | 0.00% | – |
| Q3 2022 | $44,000 | -22.8% | 6,165 | -7.7% | 0.00% | – |
| Q2 2022 | $57,000 | +26.7% | 6,679 | +34.5% | 0.00% | – |
| Q1 2022 | $45,000 | -47.1% | 4,967 | -19.2% | 0.00% | – |
| Q4 2021 | $85,000 | +28.8% | 6,150 | -1.0% | 0.00% | – |
| Q3 2021 | $66,000 | -54.5% | 6,215 | -61.5% | 0.00% | – |
| Q2 2021 | $145,000 | – | 16,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |